Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Coral Gables, FL
SEC filing record 1 source field available
Fiscal year end
31 December
RELMADA THERAPEUTICS, INC. has filed 600 SEC EDGAR filings since 13 Nov 2012

SEC filing history

Showing 251-275 of 600 matching filings.

Per page
25
Current page
11
4

4 filing

Filing date
16 Jul 2021
Reporting date
15 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-257723

REGISTRATION STATEMENT

Filing date
06 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
22 Jun 2021
Reporting date
24 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2021
Reporting date
01 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
20 May 2021
Reporting date
20 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39082

QUARTERLY REPORT

Filing date
12 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
4

4 filing

Filing date
05 May 2021
Reporting date
03 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2021
Reporting date
01 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39082

DEFINITIVE PROXY STATEMENT

Filing date
31 Mar 2021
Reporting date
20 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-39082

ANNUAL REPORT

Filing date
24 Mar 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
23 Mar 2021
Reporting date
23 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
15 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
15 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Mar 2021
Reporting date
09 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Mar 2021
Reporting date
09 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Mar 2021
Reporting date
08 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Mar 2021
Reporting date
01 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2021
Reporting date
24 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2021
Reporting date
24 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2021
Reporting date
24 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Feb 2021
Reporting date
16 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Feb 2021
Reporting date
11 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Feb 2021
Reporting date
11 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88207

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88207

AMENDMENT NO. 2

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .